e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Chronic airway disorders: miscellaneous aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent
Alexandre Chabrol (Boulogne, France), Alexandre Chabrol, Louis Jean Couderc, Elisabeth Rivaud, Emilie Catherinot, Hélène Salvator, Laurence Beaumont, Colas Tcherakian
Source:
International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Session:
Chronic airway disorders: miscellaneous aspects
Session type:
Thematic Poster Session
Number:
642
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Alexandre Chabrol (Boulogne, France), Alexandre Chabrol, Louis Jean Couderc, Elisabeth Rivaud, Emilie Catherinot, Hélène Salvator, Laurence Beaumont, Colas Tcherakian. ANCA-negative eosinophilic granulomatosis with polyangiitis (EGPA) relatead to sirolimus-eluting stent. Eur Respir J 2015; 46: Suppl. 59, 642
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Asthma follow-up and treatment in a group of 28 patients with eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA)
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013
New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA)
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (1) 00311-2019; 10.1183/23120541.00311-2019
Year: 2020
Chronic nasal inflammation in asthmatic patients with eosinophilic granulomatosis with polyangitis (EGPA)
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Granulomatosis with polyangiitis (Wegener&s)
Source: Eur Respir Mon 2011; 54: 1-14
Year: 2011
Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis
Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases
Year: 2020
Biologics for eosinophilic granulomatosis with polyangiitis
Source: Short video statement 2020
Year: 2020
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020
Year: 2020
Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
Source: Eur Respir J 2016; 48: 1429-1441
Year: 2016
Cognitive impairment in patients with eosinophilic granulomatosis with polyangiitis (EGPA): Service evaluation in a regional severe asthma centre in North-west England
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018
Co-existence of eosinophilic granulomatosis with polyangiitis, HIV and HCV infection: A rare coincidence?
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome)
Source: Eur Respir J, 57 (5) 2004158; 10.1183/13993003.04158-2020
Year: 2021
The role of intratracheal dilation – Injection technique in treatment of granulomatosis with polyangiitis (GPA) patients with subglottic stenosis
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69
Year: 2005
Secondary organizing pneumonia (BOOP)-associated with granulomatosis with polyangiitis [Wegener granulomatosis (WG)]: A clinicoradiological study of 19 cases
Source: International Congress 2014 – ILDs 6
Year: 2014
Twelve month outcomes with Reslizumab treatment of Eosinophilic Granulomatosis with Polyangiitis
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019
Nasal disease in chronic severe asthma (CSA) and eosinophilic granulomatosis with poliangiitis (EGPA)
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept